MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease

Abstract

The development of Alzheimer's disease (AD) biomarkers remains an unmet challenge, and new approaches that can improve current AD biomarker strategies are needed. Recent reports suggested that microRNA (miRNA) profiling of biological fluids has emerg